Cl.Cl.[Br:3][C:4]1[CH:5]=[C:6]([O:17][CH:18]2[CH2:22][CH2:21][NH:20][CH2:19]2)[C:7]([NH:10][C:11]2[S:12][CH:13]=[C:14]([CH3:16])[N:15]=2)=[N:8][CH:9]=1.C(N(CC)CC)C.[C:30]([Cl:33])(=[O:32])[CH3:31].Cl>O.C1COCC1>[ClH:33].[Br:3][C:4]1[CH:5]=[C:6]([O:17][CH:18]2[CH2:22][CH2:21][N:20]([C:30](=[O:32])[CH3:31])[CH2:19]2)[C:7]([NH:10][C:11]2[S:12][CH:13]=[C:14]([CH3:16])[N:15]=2)=[N:8][CH:9]=1A mixture of N-(5-bromo-3-(pyrrolidin-3-yloxy)pyridin-2-yl)-4-methylthiazol-2-amine dihydrochloride (prepared according to Example 62; 70 mg, 0.16 mmol), triethylamine (0.11 mL, 0.82 mmol), and THF (2 mL) was stirred at room temperature. Acetyl chloride (0.009 mL, 0.16 mmol) was added and stirred at room temperature for 30 minutes. Water (15 mL) was added and extracted with EtOAc. The organic layer was dried with sodium sulfate, filtered and concentrated. The residue was purified on silica gel (10% methanol in EtOAc) to afford 1-(3-(5-bromo-2-(4-methylthiazol-2-ylamino)pyridin-3-yloxy)pyrrolidin-1-yl)ethanone hydrochloride (16 mg, 22.56% yield) as a white solid after HCl salt formation. 1H NMR (d6-DMSO) δ 11.60 (bs, 1H), 8.11 (m, 1H), 7.82 (m, 1H), 6.90 (m, 1H), 5.28 (m, 1H), 3.81 (m, 1H), 3.59 (m, 3H), 2.33 (s, 3H), 2.25 (m, 2H), 1.97 (m, 3H); Mass spectrum (apci) m/z=399.1 (M+H—HCl).